Sucralose enhances GLP-1 release and lowers blood glucose in the presence of carbohydrate in healthy subjects but not in patients with type 2 diabetes

被引：0
|
作者：
S Temizkan
O Deyneli
M Yasar
M Arpa
M Gunes
D Yazici
O Sirikci
G Haklar
N Imeryuz
D G Yavuz
机构：
[1] Marmara University Faculty of Medicine,Department of Endocrinology and Metabolic Diseases
[2] Istanbul,Department of Biochemistry
[3] Turkey,Department of Gastroenterology
[4] Marmara University Faculty of Medicine,undefined
[5] Istanbul,undefined
[6] Turkey,undefined
[7] Marmara University Faculty of Medicine,undefined
来源：
European Journal of Clinical Nutrition | 2015年 / 69卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：162 / 166
页数：4
相关论文
共 50 条
  • [31] GLP-1 Agonists: Improving the Future of Patients With Type 2 Diabetes
    Shubrook, Jay H.
    JOURNAL OF THE AMERICAN OSTEOPATHIC ASSOCIATION, 2011, 111 (02): : ESII - ES1
  • [32] Additive effects of GLP-1 and pioglitazone in patients with type 2 diabetes
    Zander, M
    Christiansen, A
    Madsbad, S
    Holst, JJ
    DIABETES, 2004, 53 : A342 - A342
  • [33] GLP-1 RA and Risk of Malignancy in Patients with Type 2 Diabetes
    Ishola, Faidat A.
    Pike, C. William
    Kim, Sun H.
    DIABETES, 2024, 73
  • [34] GLP-1 as a Therapeutic Agent in Patients with Type 2 Diabetes Mellitus
    Legakis, Ioannis
    RECENT PATENTS ON ENDOCRINE METABOLIC & IMMUNE DRUG DISCOVERY, 2007, 1 (03) : 193 - 201
  • [35] Postprandial concentrations of intact and total GIP and GLP-1 in type 2 diabetic patients and healthy subjects.
    Vilsboll, T
    Krarup, T
    Deacon, C
    Madsbad, S
    Holst, JJ
    DIABETOLOGIA, 2000, 43 : A147 - A147
  • [36] Polymorphisms of GLP-1 Receptor Gene and Response to GLP-1 Analogue in Patients with Poorly Controlled Type 2 Diabetes
    Lin, Chia-Hung
    Lee, Yun-Shien
    Huang, Yu-Yao
    Hsieh, Sheng-Hwu
    Chen, Zih-Syuan
    Tsai, Chi-Neu
    JOURNAL OF DIABETES RESEARCH, 2015, 2015
  • [37] No enhancement of meal-induced GLP-1 secretion and reduced intact GLP-1 levels in Japanese patients with type 2 diabetes as well as healthy controls
    Yabe, D.
    Kuroe, A.
    Lee, S.
    Deacon, C. F.
    Watanabe, K.
    Hyo, T.
    Hishizawa, M.
    Kurose, T.
    Holst, J. J.
    Hirano, T.
    Inagaki, N.
    Seino, Y.
    DIABETOLOGIA, 2009, 52 : S312 - S312
  • [38] GLP-1 receptor agonists for type 2 diabetes
    De Block, Christophe E. M.
    Van Gaal, Luc F.
    LANCET, 2009, 374 (9683): : 4 - 6
  • [39] Determinant of the effectiveness of GLP-1 in type 2 diabetes
    Toft-Nielsen, MB
    Madsbad, S
    Damholt, MB
    Holst, JJ
    DIABETES, 2000, 49 : A127 - A127
  • [40] GLP-1 based therapy for type 2 diabetes
    Arulmozhi, DK
    Portha, B
    EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES, 2006, 28 (1-2) : 96 - 108
12345